Argenx
ARGX
#567
Rank
C$51.44 B
Marketcap
$843.49
Share price
-0.73%
Change (1 day)
58.27%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.96. In 2022 the company made an earnings per share (EPS) of -$18.78.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.59-70.23%
2022-$18.78